Impact of sequential therapy with Osimertinib on overall survival in patients with EGFR-mutant non-small cell lung cancer

Minehiko Inomata, Masahiro Matsumoto, Isami Mizushima

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	The Egyptian Journal of Bronchology
DOIs	https://doi.org/10.1186/s43168-022-00121-1
State	Published - 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{125f13d531ce445981145beef356a530,

title = "Impact of sequential therapy with Osimertinib on overall survival in patients with EGFR-mutant non-small cell lung cancer",

author = "Minehiko Inomata and Masahiro Matsumoto and {Isami Mizushima} and Shoko Matsui",

year = "2022",

doi = "10.1186/s43168-022-00121-1",

language = "American English",

journal = "The Egyptian Journal of Bronchology",

}

TY - JOUR

T1 - Impact of sequential therapy with Osimertinib on overall survival in patients with EGFR-mutant non-small cell lung cancer

AU - Inomata, Minehiko

AU - Matsumoto, Masahiro

AU - Isami Mizushima

AU - Matsui, Shoko

PY - 2022

Y1 - 2022

U2 - 10.1186/s43168-022-00121-1

DO - 10.1186/s43168-022-00121-1

M3 - Article

JO - The Egyptian Journal of Bronchology

JF - The Egyptian Journal of Bronchology

ER -